{"componentChunkName":"component---src-templates-chapter-level-2-chapter-level-2-tsx","path":"/topics/hyponatraemia/diagnosis/assessing-a-person-with-hyponatraemia/","result":{"pageContext":{"chapter":{"id":"abaaf6cd-c698-507a-8fe7-feb15605c044","slug":"assessing-a-person-with-hyponatraemia","fullItemName":"Assessing a person with hyponatraemia","depth":2,"htmlHeader":"<!-- begin field 4d1fa023-6ca6-4db8-9d77-a76900b48259 --><h2>How should I assess a person with hyponatraemia?</h2><!-- end field 4d1fa023-6ca6-4db8-9d77-a76900b48259 -->","summary":"","htmlStringContent":"<!-- begin item 91b51f2e-201d-4b90-a1a3-a76900b48106 --><!-- begin field f9295fd0-98ea-4a0b-95d6-a76900b48259 --><p><strong>For people with moderate or severe hyponatraemia and/or symptoms:</strong></p><ul><li>See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/hyponatraemia/management/management/#admission-referral\">When to admit or refer</a> for management information.</li></ul><p><strong>For people with asymptomatic, mild hyponatraemia (serum sodium concentration 130–135 mmol/L):</strong></p><ul><li><strong>Take a history to help identify an underlying <a class=\"topic-reference internal-reference\" href=\"/topics/hyponatraemia/background-information/causes/\">cause</a>.</strong><ul><li>The cause of hyponatraemia is often multifactorial and includes drugs (especially thiazide diuretics) and clinical conditions (such as the <a class=\"topic-reference internal-reference\" href=\"/topics/hyponatraemia/background-information/causes/#additional-information-on-causes\">syndrome of inappropriate antidiuretic hormone secretion</a> [SIADH], heart failure, liver disease, and kidney disease).</li><li>Ask about any intercurrent illness (such as gastroenteritis) or chronic illness (such as anorexia nervosa).</li><li>Ask about fluid intake and nocturnal polyuria (suggesting a possible diagnosis of <a class=\"topic-reference internal-reference\" href=\"/topics/hyponatraemia/background-information/causes/#additional-information-on-causes\">primary polydipsia</a>).</li></ul></li><li style=\"box-sizing: inherit;\">Examine the person to determine their<strong> volume status.</strong> <ul><li style=\"box-sizing: inherit;\">Assess for pulse rate, postural changes in blood pressure, jugular venous pressure, presence or absence of oedema, and clinical signs of dehydration. <br><ul><li>Hypovolaemia is characterized by tachycardia, postural hypotension, dry skin and mucous membranes, low urine output, decreased jugular venous pressure, and reduced skin turgor.</li><li>Hypervolaemia is characterized by peripheral, sacral, and pulmonary oedema, ascites, significant weight gain, and raised jugular venous pressure.</li><li>Determining the volume status will narrow the differential diagnosis considerably and help identify the <a class=\"topic-reference internal-reference\" href=\"/topics/hyponatraemia/background-information/causes/\">cause</a> of hyponatraemia. However, changes may be subtle and difficult to interpret.</li></ul></li></ul></li><li><strong>Arrange investigations as appropriate.</strong><ul><li>Repeat the serum sodium measurement (timescale dependant on clinical judgement) to exclude a rapidly decreasing serum sodium concentration, which will require admission to hospital.</li><li>Measure serum osmolality to differentiate between hypotonic (true) hyponatraemia, hypertonic hyponatraemia, and pseudo-hyponatraemia. See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/hyponatraemia/diagnosis/assessing-a-person-with-hyponatraemia/#interpreting-investigation-results\">Interpreting investigation results</a> for more information.</li><li>Send a urine sample to measure urinary osmolality and sodium concentration.<ul><li>Urinary osmolality provides an estimate of <a class=\"topic-reference internal-reference\" href=\"/topics/hyponatraemia/background-information/pathophysiology/\">antidiuretic hormone</a> (ADH) activity and can be used to evaluate the cause of hyponatraemia.</li><li>Urinary sodium concentration in conjunction with the person's volume status from examination may help differentiate the underlying cause of hyponatraemia.</li><li>See the section on <a class=\"topic-reference internal-reference\" href=\"/topics/hyponatraemia/diagnosis/assessing-a-person-with-hyponatraemia/#interpreting-investigation-results\">Interpreting investigation results</a> for more information.</li></ul></li><li>If clinically indicated, arrange further tests to identify an underlying cause, for example:<br><ul><li>Urinalysis for urine protein and blood — if renal disease is suspected. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/chronic-kidney-disease/\">Chronic kidney disease</a> for more information.</li><li>Thyroid function tests — if hypothyroidism is suspected. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/hypothyroidism/\">Hypothyroidism</a> for more information.</li><li>Serum cortisol (morning sample at 8–9 am) — if Addison's disease is suspected. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/addisons-disease/\">Addison's disease</a> for more information.</li><li>B-type natriuretic peptide — if heart failure is suspected.  See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/heart-failure-chronic/\">Heart failure - chronic</a> for more information.</li><li>Liver function tests — if liver disease is suspected. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/heart-failure-chronic/\">Heart failure - chronic</a> for more information.</li></ul></li></ul></li></ul><!-- end field f9295fd0-98ea-4a0b-95d6-a76900b48259 --><!-- end item 91b51f2e-201d-4b90-a1a3-a76900b48106 -->","topic":{"id":"0a0a0516-fca2-530d-88cd-096861572e3a","topicId":"560440de-b2ae-4ea7-9fb2-a701015e193f","topicName":"Hyponatraemia","slug":"hyponatraemia","lastRevised":"Last revised in November 2020","chapters":[{"id":"2d0342b8-1d8f-5b76-af1d-5c62137a465c","fullItemName":"Summary","slug":"summary","subChapters":[]},{"id":"94ef9729-defa-5118-80c3-603843005f8a","fullItemName":"Have I got the right topic?","slug":"have-i-got-the-right-topic","subChapters":[]},{"id":"0e655e55-4b6c-5ca3-9d0a-bcf5afa498d8","fullItemName":"How up-to-date is this topic?","slug":"how-up-to-date-is-this-topic","subChapters":[{"id":"262d0445-6fa5-53ed-8b8c-037da1983e4f","slug":"changes","fullItemName":"Changes"},{"id":"f79882a4-6b50-5264-a45b-2d43249a3418","slug":"update","fullItemName":"Update"}]},{"id":"8705184f-c02d-5cb2-9294-d85860c5d56e","fullItemName":"Goals and outcome measures","slug":"goals-outcome-measures","subChapters":[{"id":"815d5ca9-eab9-5381-8a01-784808ab6cc7","slug":"goals","fullItemName":"Goals"},{"id":"85b3dae2-f267-5123-913e-442f138841bb","slug":"outcome-measures","fullItemName":"Outcome measures"},{"id":"80e3ca36-d509-55eb-a763-7ccfa16bcafa","slug":"audit-criteria","fullItemName":"Audit criteria"},{"id":"e5a45e73-9ef1-5cc7-9cee-cd7c7219e953","slug":"qof-indicators","fullItemName":"QOF indicators"},{"id":"9b557451-4a38-5431-a228-8e1d27043742","slug":"qipp-options-for-local-implementation","fullItemName":"QIPP - Options for local implementation"},{"id":"3c76bef5-59b5-5e3e-b95c-72fd0f7370fb","slug":"nice-quality-standards","fullItemName":"NICE quality standards"}]},{"id":"2dda3afa-6384-564b-9938-f26680c7b906","fullItemName":"Background information","slug":"background-information","subChapters":[{"id":"c2b54f92-5f73-5871-be34-52c87c49e81f","slug":"definition","fullItemName":"Definition"},{"id":"336f0b50-af95-5811-8819-05ebe4104ffb","slug":"pathophysiology","fullItemName":"Pathophysiology"},{"id":"2f18ae19-5934-5b36-8f56-cfbc5010c984","slug":"causes","fullItemName":"Causes"},{"id":"475e9aa0-653a-537b-988e-7f4bcf86f27a","slug":"incidence-prevelance","fullItemName":"Incidence and prevelance"},{"id":"f9af97ee-3a11-59b0-9533-e9a4ed3f8900","slug":"risk-factors","fullItemName":"Risk factors"},{"id":"8887725e-10a2-544c-8f35-8094785500e3","slug":"complications","fullItemName":"Complications"}]},{"id":"1fb71225-29dc-5a7a-a4e6-edf212ae9225","fullItemName":"Diagnosis","slug":"diagnosis","subChapters":[{"id":"6c1bda17-ccd5-52a4-9299-93f536f69e45","slug":"when-to-suspect","fullItemName":"When to suspect"},{"id":"abaaf6cd-c698-507a-8fe7-feb15605c044","slug":"assessing-a-person-with-hyponatraemia","fullItemName":"Assessing a person with hyponatraemia"}]},{"id":"3f1780bb-24f2-5fae-a374-4de7113ad17f","fullItemName":"Management","slug":"management","subChapters":[{"id":"bf8b2972-5f8b-587a-935c-8f4a06208987","slug":"management","fullItemName":"Scenario: Management"}]},{"id":"23dd936f-0ccd-5303-9c4d-504c43e5f8c8","fullItemName":"Supporting evidence","slug":"supporting-evidence","subChapters":[]},{"id":"5b75e52d-5896-50b9-9baf-e0fe2b5acf38","fullItemName":"How this topic was developed","slug":"how-this-topic-was-developed","subChapters":[{"id":"6c996d4b-7572-5b4c-8adb-efc4b888b240","slug":"search-strategy","fullItemName":"Search strategy"},{"id":"a0a19e6f-1376-5caf-95d6-5492111dbefe","slug":"stakeholder-engagement","fullItemName":"Stakeholder engagement"},{"id":"73af9656-0aa1-53b8-b41a-855898c14f79","slug":"evidence-exclusion-criteria","fullItemName":"Evidence exclusion criteria"},{"id":"f9132882-237e-5da1-86ef-fac89422fbc6","slug":"organizational-behavioural-financial-barriers","fullItemName":"Organizational, behavioural and financial barriers"},{"id":"0c67dc74-d944-572d-9995-f93fb7844ef9","slug":"declarations-of-interest","fullItemName":"Declarations of interest"}]},{"id":"6781f94c-c836-5a66-b9df-5ef91879b82b","fullItemName":"References","slug":"references","subChapters":[]}]},"parentChapter":{"id":"1fb71225-29dc-5a7a-a4e6-edf212ae9225","slug":"diagnosis","fullItemName":"Diagnosis"},"subChapters":[{"id":"e9600ac1-3e81-5234-b3d2-d94f86b9469f","slug":"interpreting-investigation-results","fullItemName":"Interpreting investigation results","depth":3,"htmlHeader":"<!-- begin field 37ce1e27-cd2f-4159-81cb-ac7900a4b645 --><h3>How do I interpret plasma osmolality, urinary sodium, and urinary osmolality?</h3><!-- end field 37ce1e27-cd2f-4159-81cb-ac7900a4b645 -->","summary":null,"htmlStringContent":"<!-- begin item f4bab230-f093-4e86-9d8b-b07291083a31 --><!-- begin field 359dd0b2-c7f5-43fd-98e0-ac7900a4b645 --><ul><li><strong>Serum osmolality is a measure of the number of osmotically active solute particles (such as sodium) per kilogram of serum. </strong>It can help differentiate between hypertonic (or hyperosmolar) hyponatraemia, pseudo-hyponatraemia (or osmotic hyponatraemia), and hypotonic (or true) hyponatraemia.<ul><li><strong>Serum osmolality greater than 295 mmol/kg</strong> (high osmolality) indicates hypertonic hyponatraemia.<ul><li>Consider hyperglycaemia as a spurious cause of hyponatraemia, due to movement of water from the intracellular to extra-cellular space. See the CKS topic on <a class=\"topic-reference external-reference\" href=\"/topics/diabetes-type-2/\">Diabetes - type 2</a> for information on how to investigate for underlying type 2 diabetes.</li><li>Administration of hypertonic fluids (such as mannitol and sorbitol) can also cause hypertonic hyponatraemia.</li></ul></li><li><strong>Serum osmolality between 275–295 mOsmol/kg</strong> (normal osmolality) indicates pseudo-hyponatraemia.<ul><li>Pseudo-hyponatraemia is an artifactually (falsely) low serum sodium concentration due to hyperproteinaemia (in conditions such as multiple myeloma) or hypertriglyceridaemia. The abnormally high concentrations of proteins or lipids in the blood interfere with the accurate measurement of sodium. </li></ul></li><li><strong>Serum osmolality less than 275 mmol/kg</strong> (low osmolality) indicates hypotonic hyponatraemia.<br><ul><li>Assess for <a class=\"topic-reference internal-reference\" href=\"/topics/hyponatraemia/background-information/causes/\">causes</a> of true hyponatraemia.</li></ul></li></ul></li><li><strong>Urine osmolality <strong>is a measure of the number of osmotically active solute particles (such as sodium) per kilogram of </strong>urine. </strong>It provides an estimate of antidiuretic hormone (ADH) activity and can be used to evaluate the cause of hyponatraemia.<ul><li><strong>If the osmolality is less than or equal to 100 mOsm/kg</strong> (dilute urine), the <a class=\"topic-reference internal-reference\" href=\"/topics/hyponatraemia/background-information/pathophysiology/\">antidiuretic hormone</a> (ADH) is not acting.<ul><li>Consider primary water overload due to polydipsia, a low solute intake, or high beer intake (potomania) as a cause of hyponatraemia.</li></ul></li><li><strong>If the osmolality is more than 100 mOsm/kg</strong> (concentrated urine), ADH is acting.<ul><li>Assess for <a class=\"topic-reference internal-reference\" href=\"/topics/hyponatraemia/background-information/causes/\">causes</a> of hyponatraemia.</li></ul></li></ul></li><li><strong>Urinary sodium is a measure of the concentration of sodium in a litre of urine. </strong>Urinary sodium in conjunction with the person's <a class=\"topic-reference internal-reference\" href=\"/topics/hyponatraemia/diagnosis/assessing-a-person-with-hyponatraemia/\">volume status</a> from examination may help differentiate the underlying cause of hyponatraemia.<br><ul><li><strong>If the urine osmolality is greater than 100 mOsm/kg and the urine sodium concentration is less than or equal to 30 mmol/L:</strong><ul style=\"list-style-type: square;\" type=\"circle\"><li>In a person who is hypovolaemic, consider vomiting, diarrhoea, burns, heat exposure (sweating), third spacing, or recent past diuretic use.</li><li>In a person who is hypervolaemic, consider heart failure, liver cirrhosis, or nephrotic syndrome.</li></ul></li><li style=\"box-sizing: inherit;\"><strong>If the urine osmolality is greater than 100 mOsm/kg and the urine sodium concentration is greater than 30 mmol/L in the absence of diuretics or kidney disease:</strong><ul><li>In a person who is hypovolaemic, consider vomiting, primary adrenal insufficiency (Addison's disease), renal-salt wasting, cerebral salt wasting, or non-prescribed diuretics.</li><li>In a person who is euvolemic, consider syndrome of inappropriate antidiuresis, secondary adrenal insufficiency, hypothyroidism, or non-prescribed diuretics.</li></ul></li><li><strong>If the urine osmolality is greater than 100 mOsm/kg and the urine sodium concentration is greater than 30 mmol/L in the presence of diuretics or kidney disease:</strong><ul><li>Consider all <a class=\"topic-reference internal-reference\" href=\"/topics/hyponatraemia/background-information/causes/\">causes</a> of hyponatraemia, as diuretics and kidney disease can cause a low or a high urinary sodium concentration.</li></ul></li></ul></li></ul><!-- end field 359dd0b2-c7f5-43fd-98e0-ac7900a4b645 --><!-- end item f4bab230-f093-4e86-9d8b-b07291083a31 -->","subChapters":[]},{"id":"887596a6-9eff-501c-a872-d08751850bc4","slug":"basis-for-recommendation-bd8","fullItemName":"Basis for recommendation","depth":3,"htmlHeader":"<!-- begin field 02ab4138-20e0-4388-8be2-a76900b7d820 --><h3>Basis for recommendation</h3><!-- end field 02ab4138-20e0-4388-8be2-a76900b7d820 -->","summary":null,"htmlStringContent":"<!-- begin item bd84aa13-c8ea-4ab3-afe4-a76900b7c303 --><!-- begin field e0027d94-22e6-4365-bcd8-a76900b7d820 --><p>This information is based on expert opinion in the <em>Clinical practice guideline on diagnosis and treatment of hyponatraemia</em> developed jointly by the European Society of Intensive Care Medicine (ESICM), the European Society of Endocrinology (ESE), and the European Renal Association-European Dialysis and Transplant Association (ERA–EDTA) represented by European Renal Association (ERA) [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyponatraemia/references/\">Spasovski, 2014</a>], <em>Hyponatraemia in adults (on or after 16th birthday) </em>published by the Guideline and Audit Implementation Network (GAIN) for the Northern Ireland Department of Health [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyponatraemia/references/\">GAIN, 2010</a>], the US guideline <em>Diagnosis, evaluation, and treatment of hyponatraemia: expert panel recommendations</em> [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyponatraemia/references/\">Verbalis, 2013</a>], <em>Emergency management of severe symptomatic hyponatraemia in adult patients </em>published by the Society for Endocrinology [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyponatraemia/references/\">Ball, 2016</a>], <em>Investigation and management of hyponatraemia in adults in primary care </em>published by the York Teaching Hospital NHS Foundation Trust [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyponatraemia/references/\">Jones, 2019</a>], and on expert opinion in review articles [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyponatraemia/references/\">Saeed, 2014</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hyponatraemia/references/\">Dineen, 2017</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hyponatraemia/references/\">Woodward, 2018</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hyponatraemia/references/\">BMJ, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hyponatraemia/references/\">Jacob, 2019</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hyponatraemia/references/\">Murthy, 2019</a>]. </p><h5>History, examination, and investigations</h5><ul><li>A comprehensive history, examination, and investigations are necessary to determine the cause of hyponatraemia and guide management [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyponatraemia/references/\">GAIN, 2010</a>].</li></ul><h5>People with symptomatic hyponatraemia</h5><ul><li>Expert opinion in the Society for Endocrinology guideline is that people with severe symptoms require immediate treatment with hypertonic saline, irrespective of the cause of the hyponatraemia [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyponatraemia/references/\">Ball, 2016</a>]. </li><li>Expert opinion in a review article is that acute symptomatic hyponatraemia is a medical emergency, and treatment should not be delayed pending a diagnosis of the cause of hyponatraemia [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyponatraemia/references/\">Woodward, 2018</a>].</li></ul><h5>Interpreting the results of tests</h5><ul><li>Experts agree that measurement of serum osmolality, urine osmolality, and urine sodium concentration help to determine the underlying cause of hyponatraemia [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyponatraemia/references/\">Ball, 2016</a>; <a class=\"bibliography-reference internal-reference\" href=\"/topics/hyponatraemia/references/\">BMJ, 2019</a>], particularly in the absence of clear comorbidities [<a class=\"bibliography-reference internal-reference\" href=\"/topics/hyponatraemia/references/\">Saeed, 2014</a>].</li></ul><!-- end field e0027d94-22e6-4365-bcd8-a76900b7d820 --><!-- end item bd84aa13-c8ea-4ab3-afe4-a76900b7c303 -->","subChapters":[]}]}}},"staticQueryHashes":["3666801979"]}